key: cord-0879162-o05yp746 authors: Ojha, Rupal; Gupta, Nidhi; Naik, Biswajit; Singh, Satyendra; Verma, Vijay Kumar; Prusty, Dhaneswar; Prajapati, Vijay Kumar title: High throughput and comprehensive approach to develop multiepitope vaccine against minacious COVID-19 date: 2020-05-14 journal: Eur J Pharm Sci DOI: 10.1016/j.ejps.2020.105375 sha: feb187c73b33d8dc25b4cb33724e98c7906bfeb7 doc_id: 879162 cord_uid: o05yp746 The ongoing enigmatic COVID-19 outbreak, first reported from Wuhan, China, on last day of the year 2019, which has spread to 213 countries, territories/areas till 28(th) April, 2020, threatens hundreds of thousands human souls. This devastating viral infection has stimulated the urgent development of viable vaccine against COVID-19 across the research institutes around the globe. The World Health Organization (WHO) has also confirmed that the recent pandemic is causing Public Health Emergency of International apprehension. Moreover, the earlier two pathogenic SARS-CoV and MERS-CoV and many others yet to be identified pose a universal menace. Here, in this piece of work, we have utilized an in silico structural biology and advanced immunoinformatic strategies to devise a multi-epitope subunit vaccine against ongoing COVID-19 infection. The engineered vaccine sequence is adjuvanted with ß-3 defensin and comprised of B-cell epitopes, HTL epitopes and CTL epitopes. This is very likely that the vaccine will be able to elicit the strong immune response. Further, specific binding of the engineered vaccine and immune cell receptor TLR3 was estimated by molecular interaction studies. Strong interaction in the binding groove as well as good docking scores affirmed the stringency of engineered vaccine. The interaction is stable with minimal deviation in root-mean square deviation and root-mean-square fluctuation was confirmed by the molecular dynamics simulation experiment. The immune-simulation by C-ImmSim server, which mimics the natural immune environment, yielded more potent immune response data of B-cells, Th cells, Tc cells and IgG for vaccine. The encouraging data obtained from the various in-silico works indicated this vaccine as an effective therapeutic against COVID-19. Hypothetically, almost all proteins of the miniature organism (viruses) are potential vaccine 116 targets (Shi et al., 2015) . In an incredibly fast piece of study, it has been shown that once this 117 virus installed itself into the human body, it encodes its "tool proteins" which helps in the 118 replication. These "tool proteins" i.e. non-structural proteins are the key (toolkit) to 119 synthesize the other structural proteins (Spike, Membrane, Envelope and Nucleocapsid) and 120 factors which requires to grow its progeny (Lewis et al., 2020) . In our strategy of vaccine 121 development, we have engineered the toolkit i.e. non-structural proteins which includes 3-C 122 like proteinase (YP_009725301.1), RNA dependent RNA polymerase (YP_009725307.1), 123 Helicase (YP_009725308.1), 3'-5' exonuclease (YP_009725309.1), 2'-O-ribo methyl 124 transferase (YP_009725311.1) & endoRNase (YP_009725310.1). All these proteins have 125 also used as a drug target for commercially available antiviral drugs to fight against sudden 126 outbreak of COVID-19, since there are no specific antivirals available (Beck et al., 2020) . 127 Further, several non-structural proteins make the replicase-transcriptase complex, which 128 ultimately helps in the replication and transcription of virus genomic RNA (Ziebuhr, 2005) . The 3-C like proteinase is a protease present in all coronaviruses, which helps in proteolysis 130 of the non-structural protein 5 (nsp5) during replication process of virus (Tomar et al., 2015) . This makes it a high value vaccine candidate against the coronavirus. Further, a key enzyme 132 of coronavirus replication and transcription system is RNA-dependent RNA polymerase 133 (RdRp), which is encoded by nsp12, also appears as an attractive target for therapeutics (Gao Prediction of Cytotoxic T Lymphocytes (CTL) epitopes for vaccine designing 185 The CTL epitopes for vaccine designing were predicted by using NetCTL 1.2 server 186 (http://www.cbs.dtu.dk/services/NetCTL/). This server comprises of two datasets, one is of 187 HIV (human immunodeficiency virus) CTL epitopes and other one is their source proteins. The proteins present in the datasets have been cleaved into all probable 9 mers. The exception 189 was only for the annotated epitopes and the remaining ones are considered as non-epitopes. The protein sequences in FASTA has been required as input for the prediction of potential Apart from this, the average antigenic propensity of the designed vaccine candidate was Grand average of hydropathicity (GRAVY) 0.060 candidate was probably non-allergen and will not lead to any allergy during pre and post 454 vaccination. Subsequently, with the help of ToxinPred server we have checked the toxicity of 455 the epitopes, as this server accepts the protein sequences of >500 amino acids and here, in 456 this study the designed vaccine candidate was of 561 amino acid. So, after doing this it was 457 found that all the epitopes involved in the designing of vaccine candidate was non-toxic and 458 will not release any toxic components after administration (Supplementary table-5A, 5B and 459 5C). This above data suggested that the designed vaccine candidate was highly stable, RaptorX server. Tertiary structure refinement and validation 485 The tertiary structure refinement was achieved with the help of 3D refine server. As an output 486 the server generated five refined models and the selection of best model was done on the 487 basis of various parameters. The model number fifth was selected as its 3D refine score was 488 40460.5 which was less than all the other four models. Additionally, the GDT-TS score of the 489 selected model was 0.9960 whereas the GDT-HA score was 0.9501, these higher scores 490 denotes the conservative refinement. Next, the RMSD (root mean square deviation) was 491 0.450, this higher score indicates the aggressive refinement in comparison to initial non-492 refined one. The MolProbity score was 3.790 and the RWPlus (potential energy) score was - The score obtained by QMEAN4 server was -7.25 whereas the global IDDT score of the 501 model was 0.9182 (this score should be ranges between 0 and 1). Next, with the help of 502 QMEANDisCo scoring function we have predicted the global quality of model, the obtained 503 global score was 0.35 ± 0.05. This data suggested that the score (global, local, IDDT) 504 obtained for our model structure was higher and in between the range, hence, we can 505 conclude that designed model has best scoring and was of exceptional quality (Figure-4) . reported that mice lacking TLR3 and TLR4 are more vulnerable to SARS-CoV in 540 comparison to mice having TLR3 and TLR4 receptors; exceptionally weight loss was 541 observed when exposed to infection, but no mortality was detected (Totura et al., 2015) . One immune receptor TLR-3 using HADDOCK server. The immune simulation experiment was performed using C-ImmSim server which, gives a 595 real immune response result. In our results, we have observed the proliferation in secondary 596 and tertian immune response which is identified by IgG1 + IgG2 and IgM. Also, while 597 decreasing the antigen count IgG + IgM also showed the proliferated response in Figure 8 A. Result revealed the immune response development upon immunization. B-cell population 599 level was also stimulated and seems to be very high upon immunization (Figure 8 B) . GROMACS: High performance molecular simulations through multi-level parallelism from 658 laptops to supercomputers Biochemical Characterization of Middle East 660 Respiratory Syndrome Coronavirus Helicase. mSphere Predicting commercially 662 available antiviral drugs that may act on the novel coronavirus (2019-nCoV), Wuhan, China 663 through a drug-target interaction deep learning model QMEAN server for protein model quality 665 estimation The severe acute respiratory syndrome 667 coronavirus Nsp15 protein is an endoribonuclease that prefers manganese as a cofactor 3Drefine: an interactive web server 670 for efficient protein structure refinement Coronavirus avian infectious bronchitis virus Outbreak of severe acute respiratory syndrome in Hong 674 Kong Special Administrative Region: case report Novel coronavirus: where we are and what we know The HADDOCK web server for 678 data-driven biomolecular docking Identification of Potential MHC 681 Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse 682 Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral 683 AllerTOP-a server for in silico prediction 685 of allergens Structure of the RNA-dependent RNA polymerase from COVID-19 virus Receptor-ligand based molecular interaction to discover adjuvant for immune cell TLRs to 691 develop next-generation vaccine Peptide 693 toxicity prediction, Computational Peptidology Clinical features of patients infected with 2019 novel coronavirus in Wuhan Pathogenicity of turkey coronavirus in turkeys and 698 chickens RaptorX server: a resource for 700 template-based protein structure modeling Advantages of a synthetic peptide 702 immunogen over a protein immunogen in the development of an anti-pilus vaccine for 703 Pseudomonas aeruginosa Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction Vaccine Will Close in on the Spikes A rational strategy to design multiepitope immunogens based on multiple Th 711 lymphocyte epitopes Structure validation by Calpha geometry: phi,psi 714 and Cbeta deviation Modulation of HIV peptide antigen 716 specific cellular immune response by synthetic α-and β-defensin peptides Use of Reverse Vaccinology in the Design and 720 Construction of Nanoglycoconjugate Vaccines against Conglomeration of novel Culex 723 quinquefasciatus salivary proteins to contrive multi-epitope subunit vaccine against infections 724 caused by blood imbibing transmitter Contriving multiepitope subunit vaccine by 726 exploiting structural and nonstructural viral proteins to prevent Epstein-Barr virus-associated 727 malignancy Vaccinomics strategy to concoct a promising 729 subunit vaccine for visceral leishmaniasis targeting sandfly and leishmania antigens Next-Generation Multi-Epitope Vaccine To Prevent Nipah Virus Zoonotic Infection COVID-19 coronavirus vaccine design 735 using reverse vaccinology and machine learning Combinatorial screening algorithm to engineer multiepitope subunit vaccine targeting human 738 T-lymphotropic virus-1 infection An introduction to sequence similarity ("homology") searching. Current 740 protocols in bioinformatics Chapter Severe acute respiratory syndrome Computational immunology meets 744 bioinformatics: the use of prediction tools for molecular binding in the simulation of the 745 immune system AlgPred: prediction of allergenic proteins and mapping 747 of IgE epitopes Prediction methods for B-cell epitopes Nine major HLA class I supertypes account for the vast 751 preponderance of HLA-A and -B polymorphism The Utility of Supertype 753 Clustering in Prediction for Class II MHC-Peptide Binding Epitope-based vaccine target screening against highly pathogenic MERS-CoV: an in 756 silico approach applied to emerging infectious diseases Unique and conserved features 759 of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 760 2 lineage Epidemiology, genetic recombination, and pathogenesis of coronaviruses East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro) IMPLICATIONS 767 FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS Toll-like receptor 3 signaling via TRIF contributes to a protective innate 771 immune response to severe acute respiratory syndrome coronavirus infection 774 GROMACS: fast, flexible, and free The immune epitope 777 database (IEDB) 3.0 An ingenious design for peptide vaccines Fatal swine acute diarrhoea syndrome caused by an HKU2-related 782 coronavirus of bat origin A novel coronavirus from patients with pneumonia in China The coronavirus replicase, Coronavirus replication and reverse genetics Vaccine against Middle 789 East respiratory syndrome coronavirus Acknowledgment: RO is thankful to UGC for providing university fellowship. VKP is